[1]
“Prime Editing in Neurogenetic Disorders: Molecular Mechanisms, Therapeutic Applications, and Translational Challenges”, MSAR Med Sci, vol. 1, no. 1, pp. 1–3, Nov. 2026, doi: 10.68041/medsc.v1i1/01.